KURA
NASDAQ · Biotechnology
Kura Oncology Inc
$7.27
+0.47 (+6.91%)
Open$6.91
Previous Close$6.80
Day High$7.40
Day Low$6.75
52W High$13.90
52W Low$6.76
Volume—
Avg Volume2.50M
Market Cap647.19M
P/E Ratio—
EPS$-3.36
SectorBiotechnology
Analyst Ratings
Strong Buy
22 analysts
Price Target
+531.6% upside
Current
$7.27
$7.27
Target
$45.92
$45.92
$25.11
$45.92 avg
$52.51
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 48.55M | 146.41M | 142.51M |
| Net Income | -200,489,661 | 21.31M | 25.50M |
| Profit Margin | -413.0% | 14.6% | 17.9% |
| EBITDA | -217,703,866 | 41.90M | 41.44M |
| Free Cash Flow | — | 24.20M | 22.28M |
| Rev Growth | — | -6.0% | +22.0% |
| Debt/Equity | 0.06 | 0.38 | 0.34 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $293.30 | +0.68% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $463.45 | +0.66% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $169.25 | +1.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $549.39 | +0.42% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $922.99 | +2.06% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.52 | +0.37% | 7.7 | 20.98B |